Avraham Yaron - Publications

Affiliations: 
Biological Chemistry Weizmann Institute of Science, Rehovot, Israel 
Area:
Axon guidence

37/168 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Danelon V, Goldner R, Martinez E, Gokhman I, Wang K, Yaron A, Tran TS. Modular and distinct PlexinA4/Farp2/Rac1 signaling controls dendrite morphogenesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32499377 DOI: 10.1523/JNEUROSCI.2730-19.2020  0.52
2020 Ulisse V, Dey S, Rothbard DE, Zeevi E, Gokhman I, Dadosh T, Minis A, Yaron A. Regulation of axonal morphogenesis by the mitochondrial protein Efhd1. Life Science Alliance. 3. PMID 32414840 DOI: 10.26508/lsa.202000753  0.52
2018 Shacham-Silverberg V, Sar Shalom H, Goldner R, Golan-Vaishenker Y, Gurwicz N, Gokhman I, Yaron A. Phosphatidylserine is a marker for axonal debris engulfment but its exposure can be decoupled from degeneration. Cell Death & Disease. 9: 1116. PMID 30389906 DOI: 10.1038/s41419-018-1155-z  0.52
2016 Wong E, Cohen T, Romi E, Levin M, Peleg Y, Arad U, Yaron A, Milla ME, Sagi I. Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo. Scientific Reports. 6: 35598. PMID 27982031 DOI: 10.1038/srep35598  0.32
2016 Maor-Nof M, Romi E, Shalom HS, Ulisse V, Raanan C, Nof A, Leshkowitz D, Lang R, Yaron A. Axonal Degeneration Is Regulated by a Transcriptional Program that Coordinates Expression of Pro- and Anti-degenerative Factors. Neuron. PMID 27889097 DOI: 10.1016/j.neuron.2016.10.061  0.32
2015 Schuldiner O, Yaron A. Mechanisms of developmental neurite pruning. Cellular and Molecular Life Sciences : Cmls. 72: 101-19. PMID 25213356 DOI: 10.1007/s00018-014-1729-6  0.8
2014 Romi E, Gokhman I, Wong E, Antonovsky N, Ludwig A, Sagi I, Saftig P, Tessier-Lavigne M, Yaron A. ADAM metalloproteases promote a developmental switch in responsiveness to the axonal repellant Sema3A. Nature Communications. 5: 4058. PMID 24898499 DOI: 10.1038/ncomms5058  0.8
2014 Mlechkovich G, Peng SS, Shacham V, Martinez E, Gokhman I, Minis A, Tran TS, Yaron A. Distinct cytoplasmic domains in Plexin-A4 mediate diverse responses to semaphorin 3A in developing mammalian neurons. Science Signaling. 7: ra24. PMID 24619647 DOI: 10.1126/scisignal.2004734  0.8
2014 Sar Shalom H, Yaron A. Marking axonal growth in sensory neurons: SCG10. Experimental Neurology. 254: 68-9. PMID 24472661 DOI: 10.1016/j.expneurol.2014.01.014  0.8
2014 Minis A, Dahary D, Manor O, Leshkowitz D, Pilpel Y, Yaron A. Subcellular transcriptomics-dissection of the mRNA composition in the axonal compartment of sensory neurons. Developmental Neurobiology. 74: 365-81. PMID 24127433 DOI: 10.1002/dneu.22140  0.8
2013 Maor-Nof M, Yaron A. Neurite pruning and neuronal cell death: spatial regulation of shared destruction programs. Current Opinion in Neurobiology. 23: 990-6. PMID 23871216 DOI: 10.1016/j.conb.2013.06.007  0.8
2013 Maor-Nof M, Homma N, Raanan C, Nof A, Hirokawa N, Yaron A. Axonal pruning is actively regulated by the microtubule-destabilizing protein kinesin superfamily protein 2A. Cell Reports. 3: 971-7. PMID 23562155 DOI: 10.1016/j.celrep.2013.03.005  0.8
2013 Hanada T, Weitzer S, Mair B, Bernreuther C, Wainger BJ, Ichida J, Hanada R, Orthofer M, Cronin SJ, Komnenovic V, Minis A, Sato F, Mimata H, Yoshimura A, Tamir I, ... ... Yaron A, et al. CLP1 links tRNA metabolism to progressive motor-neuron loss. Nature. 495: 474-80. PMID 23474986 DOI: 10.1038/nature11923  0.8
2013 Rishal I, Golani O, Rajman M, Costa B, Ben-Yaakov K, Schoenmann Z, Yaron A, Basri R, Fainzilber M, Galun M. WIS-NeuroMath enables versatile high throughput analyses of neuronal processes. Developmental Neurobiology. 73: 247-56. PMID 23055261 DOI: 10.1002/dneu.22061  0.8
2012 Perry RB, Doron-Mandel E, Iavnilovitch E, Rishal I, Dagan SY, Tsoory M, Coppola G, McDonald MK, Gomes C, Geschwind DH, Twiss JL, Yaron A, Fainzilber M. Subcellular knockout of importin β1 perturbs axonal retrograde signaling. Neuron. 75: 294-305. PMID 22841314 DOI: 10.1016/j.neuron.2012.05.033  0.8
2012 Amit S, Yaron A. Novel systems for in vivo monitoring and microenvironmental investigations of diabetic neuropathy in a murine model. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 1317-25. PMID 22592935 DOI: 10.1007/s00702-012-0808-9  0.8
2012 Yaron A, Sprinzak D. The cis side of juxtacrine signaling: a new role in the development of the nervous system. Trends in Neurosciences. 35: 230-9. PMID 22222351 DOI: 10.1016/j.tins.2011.12.003  0.8
2011 Scott A, Hasegawa H, Sakurai K, Yaron A, Cobb J, Wang F. Transcription factor short stature homeobox 2 is required for proper development of tropomyosin-related kinase B-expressing mechanosensory neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 6741-9. PMID 21543603 DOI: 10.1523/JNEUROSCI.5883-10.2011  0.8
2010 Haklai-Topper L, Mlechkovich G, Savariego D, Gokhman I, Yaron A. Cis interaction between Semaphorin6A and Plexin-A4 modulates the repulsive response to Sema6A. The Embo Journal. 29: 2635-45. PMID 20606624 DOI: 10.1038/emboj.2010.147  0.8
2010 Schoenmann Z, Assa-Kunik E, Tiomny S, Minis A, Haklai-Topper L, Arama E, Yaron A. Axonal degeneration is regulated by the apoptotic machinery or a NAD+-sensitive pathway in insects and mammals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 6375-86. PMID 20445064 DOI: 10.1523/JNEUROSCI.0922-10.2010  0.8
2008 Ben-Zvi A, Manor O, Schachner M, Yaron A, Tessier-Lavigne M, Behar O. The Semaphorin receptor PlexinA3 mediates neuronal apoptosis during dorsal root ganglia development. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 12427-32. PMID 19020035 DOI: 10.1523/JNEUROSCI.3573-08.2008  0.8
2008 Bechara A, Nawabi H, Moret F, Yaron A, Weaver E, Bozon M, Abouzid K, Guan JL, Tessier-Lavigne M, Lemmon V, Castellani V. FAK-MAPK-dependent adhesion disassembly downstream of L1 contributes to semaphorin3A-induced collapse. The Embo Journal. 27: 1549-62. PMID 18464795 DOI: 10.1038/emboj.2008.86  0.8
2007 Yaron A, Zheng B. Navigating their way to the clinic: emerging roles for axon guidance molecules in neurological disorders and injury. Developmental Neurobiology. 67: 1216-31. PMID 17514715 DOI: 10.1002/dneu.20512  0.8
2005 Friedel RH, Plump A, Lu X, Spilker K, Jolicoeur C, Wong K, Venkatesh TR, Yaron A, Hynes M, Chen B, Okada A, McConnell SK, Rayburn H, Tessier-Lavigne M. Gene targeting using a promoterless gene trap vector ("targeted trapping") is an efficient method to mutate a large fraction of genes. Proceedings of the National Academy of Sciences of the United States of America. 102: 13188-93. PMID 16129827 DOI: 10.1073/pnas.0505474102  0.8
2005 Yaron A, Huang PH, Cheng HJ, Tessier-Lavigne M. Differential requirement for Plexin-A3 and -A4 in mediating responses of sensory and sympathetic neurons to distinct class 3 Semaphorins. Neuron. 45: 513-23. PMID 15721238 DOI: 10.1016/j.neuron.2005.01.013  0.8
2003 Bagri A, Cheng HJ, Yaron A, Pleasure SJ, Tessier-Lavigne M. Stereotyped pruning of long hippocampal axon branches triggered by retraction inducers of the semaphorin family. Cell. 113: 285-99. PMID 12732138 DOI: 10.1016/S0092-8674(03)00267-8  0.8
2002 Davis M, Hatzubai A, Andersen JS, Ben-Shushan E, Fisher GZ, Yaron A, Bauskin A, Mercurio F, Mann M, Ben-Neriah Y. Pseudosubstrate regulation of the SCF(beta-TrCP) ubiquitin ligase by hnRNP-U. Genes & Development. 16: 439-51. PMID 11850407 DOI: 10.1101/gad.218702  0.8
2001 Cheng HJ, Bagri A, Yaron A, Stein E, Pleasure SJ, Tessier-Lavigne M. Plexin-A3 mediates semaphorin signaling and regulates the development of hippocampal axonal projections. Neuron. 32: 249-63. PMID 11683995 DOI: 10.1016/S0896-6273(01)00478-0  0.8
2001 Marín O, Yaron A, Bagri A, Tessier-Lavigne M, Rubenstein JL. Sorting of striatal and cortical interneurons regulated by semaphorin-neuropilin interactions. Science (New York, N.Y.). 293: 872-5. PMID 11486090 DOI: 10.1126/science.1061891  0.8
1998 Yaron A, Hatzubai A, Davis M, Lavon I, Amit S, Manning AM, Andersen JS, Mann M, Mercurio F, Ben-Neriah Y. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature. 396: 590-4. PMID 9859996 DOI: 10.1038/25159  0.8
1997 Yaron A, Gonen H, Alkalay I, Hatzubai A, Jung S, Beyth S, Mercurio F, Manning AM, Ciechanover A, Ben-Neriah Y. Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase. The Embo Journal. 16: 6486-94. PMID 9351830 DOI: 10.1093/emboj/16.21.6486  0.8
1995 Ben-Neriah Y, Alkalay I, Yaron A, Hatzubai A, Jung S. Signalling intermediates of CD28. Research in Immunology. 146: 154-8. PMID 8525045 DOI: 10.1016/0923-2494(96)80249-5  0.8
1995 Alkalay I, Yaron A, Hatzubai A, Jung S, Avraham A, Gerlitz O, Pashut-Lavon I, Ben-Neriah Y. In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B. Molecular and Cellular Biology. 15: 1294-301. PMID 7862123  0.8
1995 Jung S, Yaron A, Alkalay I, Hatzubai A, Avraham A, Ben-Neriah Y. Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells. Annals of the New York Academy of Sciences. 766: 245-52. PMID 7486667 DOI: 10.1111/j.1749-6632.1995.tb26672.x  0.8
1995 Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben-Neriah Y. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Proceedings of the National Academy of Sciences of the United States of America. 92: 10599-603. PMID 7479848 DOI: 10.1073/pnas.92.23.10599  0.8
1994 Gnatt A, Loewenstein Y, Yaron A, Schwarz M, Soreq H. Site-directed mutagenesis of active site residues reveals plasticity of human butyrylcholinesterase in substrate and inhibitor interactions. Journal of Neurochemistry. 62: 749-55. PMID 8294937  0.8
1994 Lev-Lehman E, el-Tamer A, Yaron A, Grifman M, Ginzberg D, Hanin I, Soreq H. Cholinotoxic effects on acetylcholinesterase gene expression are associated with brain-region specific alterations in G,C-rich transcripts. Brain Research. 661: 75-82. PMID 7834388 DOI: 10.1016/0006-8993(94)91183-5  0.8
Low-probability matches
2017 Wolf Y, Boura-Halfon S, Cortese N, Haimon Z, Shalom HS, Kuperman Y, Kalchenko V, Brandis A, David E, Segal-Hayoun Y, Chappell-Maor L, Yaron A, Jung S. Brown-adipose-tissue macrophages control tissue innervation and homeostatic energy expenditure. Nature Immunology. PMID 28459435 DOI: 10.1038/ni.3746  0.28
2004 Storesletten K, Telmer CI, Yaron A. Consumption and risk sharing over the life cycle Journal of Monetary Economics. 51: 609-633. DOI: 10.1016/j.jmoneco.2003.06.005  0.01
1965 Lupu-Lotan N, Yaron A, Berger A, Sela M. Conformation changes in the nonionizable water-soluble synthetic polypeptide poly-N5-(3-hydroxypropl)-1-glutamine. Biopolymers. 3: 625-55. PMID 5853843 DOI: 10.1002/bip.360030604  0.24
2016 Perry RB, Rishal I, Doron-Mandel E, Kalinski AL, Medzihradszky KF, Terenzio M, Alber S, Koley S, Lin A, Rozenbaum M, Yudin D, Sahoo PK, Gomes C, Shinder V, Geraisy W, ... ... Yaron A, et al. Nucleolin-Mediated RNA Localization Regulates Neuron Growth and Cycling Cell Size. Cell Reports. PMID 27477284 DOI: 10.1016/j.celrep.2016.07.005  0.16
2004 Storesletten K, Telmer CI, Yaron A. Cyclical dynamics in idiosyncratic labor market risk Journal of Political Economy. 112: 695-717. DOI: 10.1086/383105  0.01
2001 Storesletten K, Telmer CI, Yaron A. How important are idiosyncratic shocks? Evidence from labor supply American Economic Review. 91: 413-417.  0.01
1981 Fleminger G, Goldenberg D, Yaron A. Use of an intramolecularly quenched fluorogenic substrate for study of a thiol-dependent acidic dipeptidyl carboxypeptidase in cellular extracts and in living cells. Febs Letters. 135: 131-4. PMID 7032965 DOI: 10.1016/0014-5793(81)80960-X  0.08
1979 Hoekstra D, Yaron A, Carmel A, Scherphof G. Fusion of phospholipid vesicles containing a trypsin-sensitive fluorogenic substrate and trypsin: a new method to study membrane fusion activity in a model system. Febs Letters. 106: 176-80. PMID 499492 DOI: 10.1016/0014-5793(79)80722-X  0.08
2002 Dan JA, Honavar SG, Belyea DA, Mandal AK, Garudadri C, Levy B, Ramakrishnan R, Krishnadas R, Lieberman MF, Stamper RL, Yaron A. Enzymatic sclerostomy: pilot human study. Archives of Ophthalmology (Chicago, Ill. : 1960). 120: 548-53. PMID 12003602  0.08
2002 Dan JA, Honavar SG, Belyea DA, Mandal AK, Garudadri C, Levy B, Ramakrishnan R, Krishnadas R, Lieberman MF, Stamper RL, Yaron A, Parrish RK. Enzymatic sclerostomy pilot human study Evidence-Based Eye Care. 3: 200-201. DOI: 10.1097/00132578-200210000-00016  0.08
2001 Storesletten K, Telmer CI, Yaron A. The welfare cost of business cycles revisited: Finite lives and cyclical variation in idiosyncratic risk European Economic Review. 45: 1311-1339. DOI: 10.1016/S0014-2921(00)00101-X  0.01
1994 Dan JA, Yaron A. Focal scleral permeability enhanced by collagenase digestion. Experimental model of enzymatic sclerostomy. Ophthalmology. 101: 461-72. PMID 8127566  0.08
1994 Tanaka T, Duke-Cohan JS, Kameoka J, Yaron A, Lee I, Schlossman SF, Morimoto C. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proceedings of the National Academy of Sciences of the United States of America. 91: 3082-6. PMID 7909158  0.08
1993 Yaron A, Naider F. Proline-dependent structural and biological properties of peptides and proteins. Critical Reviews in Biochemistry and Molecular Biology. 28: 31-81. PMID 8444042 DOI: 10.3109/10409239309082572  0.08
1993 Tanaka T, Kameoka J, Yaron A, Schlossman SF, Morimoto C. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proceedings of the National Academy of Sciences of the United States of America. 90: 4586-90. PMID 7685106  0.08
1992 Vanhoof G, De Meester I, Goossens F, Hendriks D, Scharpé S, Yaron A. Kininase activity in human platelets: cleavage of the Arg1-Pro2 bond of bradykinin by aminopeptidase P. Biochemical Pharmacology. 44: 479-87. PMID 1510698 DOI: 10.1016/0006-2952(92)90439-P  0.08
1992 Rusu I, Yaron A. Aminopeptidase P from human leukocytes. European Journal of Biochemistry / Febs. 210: 93-100. PMID 1446689 DOI: 10.1111/j.1432-1033.1992.tb17395.x  0.08
1992 Vanhoof G, De Meester I, van Sande M, Scharpé S, Yaron A. Distribution of proline-specific aminopeptidases in human tissues and body fluids. European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies. 30: 333-8. PMID 1380841 DOI: 10.1515/cclm.1992.30.6.333  0.08
1992 Vanhoof G, de Meester I, Hendriks D, Goossens F, van Sande M, Scharpé S, Yaron A. Proline-specific aminopeptidases: potential role in bradykinin degradation. Agents and Actions. Supplements. 38: 120-7. PMID 1361094  0.08
1992 De Meester I, Vanhoof G, Hendriks D, Demuth HU, Yaron A, Scharpé S. Characterization of dipeptidyl peptidase IV (CD26) from human lymphocytes. Clinica Chimica Acta; International Journal of Clinical Chemistry. 210: 23-34. PMID 1358482 DOI: 10.1016/0009-8981(92)90042-O  0.08
1992 Ezra Y, Simon A, Yaron A, Laufer N, Navot D. Angiotensin-I-converting enzyme and its correlation with human follicular fluid steroids. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 44: 71-5. PMID 1316850 DOI: 10.1016/0028-2243(92)90316-Q  0.08
1991 Hendriks D, De Meester I, Umiel T, Vanhoof G, van Sande M, Scharpé S, Yaron A. Aminopeptidase P and dipeptidyl peptidase IV activity in human leukocytes and in stimulated lymphocytes. Clinica Chimica Acta; International Journal of Clinical Chemistry. 196: 87-96. PMID 1674239 DOI: 10.1016/0009-8981(91)90061-G  0.08
1991 Scharpé SL, Vanhoof GC, De Meester IA, Hendriks DF, van Sande ME, Muylle LM, Yaron A. Exopeptidases in human platelets: an indication for proteolytic modulation of biologically active peptides. Clinica Chimica Acta; International Journal of Clinical Chemistry. 195: 125-31. PMID 1674236 DOI: 10.1016/0009-8981(91)90132-V  0.08
1990 Naider F, Yaron A, Ewenson A, Tallon M, Xue CB, Srinivasan JV, Eriotou-Bargiota E, Becker JM. Synthetic probes for the alpha-factor receptor. Biopolymers. 29: 237-45. PMID 2158359 DOI: 10.1002/bip.360290128  0.08
1990 de Meester I, Vanhoof G, Scharpé S, Hendriks D, van Sande M, Yaron A. Dipeptidyl peptidase IV in human lymphocytes: molecular properties. Biochemical Society Transactions. 18: 671-2. PMID 1980467  0.08
1988 Scharpé S, De Meester I, Vanhoof G, Hendriks D, van Sande M, Van Camp K, Yaron A. Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphthylamine. Clinical Chemistry. 34: 2299-301. PMID 2902942  0.08
1988 Peleg E, Peleg D, Yaron A, Goldman JA, Rosenthal T. Perinatal development of angiotensin-converting enzyme in the rat's blood. Gynecologic and Obstetric Investigation. 25: 12-5. PMID 2830179 DOI: 10.1159/000293738  0.08
1988 Nussinovitch N, Peleg E, Yaron A, Ratt P, Rosenthal T. Angiotensin converting enzyme in bleomycin-treated patients. International Journal of Clinical Pharmacology, Therapy, and Toxicology. 26: 310-3. PMID 2457562  0.08
1987 Holtzman EJ, Pillay G, Rosenthal T, Yaron A. Aminopeptidase P activity in rat organs and human serum. Analytical Biochemistry. 162: 476-84. PMID 3605610 DOI: 10.1016/0003-2697(87)90423-4  0.08
1987 Yaron A. The role of proline in the proteolytic regulation of biologically active peptides. Biopolymers. 26: S215-22. PMID 3580498 DOI: 10.1002/bip.360260019  0.08
1987 Fleminger G, Yaron A. [17] Application of immobilized aminopeptidases to the sequential hydrolysis of proline-containing peptides Methods in Enzymology. 136: 170-178. DOI: 10.1016/S0076-6879(87)36019-7  0.08
1984 Fleminger G, Yaron A. Soluble and immobilized clostridial aminopeptidase and aminopeptidase P as metal-requiring enzymes. Biochimica Et Biophysica Acta. 789: 245-56. PMID 6477932 DOI: 10.1016/0167-4838(84)90180-8  0.08
1984 Dux S, Yaron A, Carmel A, Rosenfeld JB. Renin, aldosterone, and serum-converting enzyme activity during normal and hypertensive pregnancy. Gynecologic and Obstetric Investigation. 17: 252-7. PMID 6329926 DOI: 10.1159/000299158  0.08
1984 Dux S, Aron N, Boner G, Carmel A, Yaron A, Rosenfeld JB. Serum angiotensin converting enzyme activity in normal adults and patients with different types of hypertension. Israel Journal of Medical Sciences. 20: 1138-42. PMID 6097566  0.08
1984 Neels HM, Scharpé SL, Fonteyne GA, Yaron A, van Sande ME. Fluorometric assay for angiotensin converting enzyme in human serum by centrifugal analysis. Clinica Chimica Acta; International Journal of Clinical Chemistry. 141: 281-6. PMID 6091950 DOI: 10.1016/0009-8981(84)90022-6  0.08
1983 Fleminger G, Yaron A. Sequential hydrolysis of proline-containing peptides with immobilized aminopeptidases. Biochimica Et Biophysica Acta. 743: 437-46. PMID 6830820 DOI: 10.1016/0167-4838(83)90403-X  0.08
1982 Fleminger G, Carmel A, Goldenberg D, Yaron A. Fluorogenic substrates for bacterial aminopeptidase P and its analogs detected in human serum and calf lung. European Journal of Biochemistry / Febs. 125: 609-15. PMID 6749499  0.08
1982 Holtzman E, Rosenthal T, Stern N, Knecht A, Yaron A. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension. Israel Journal of Medical Sciences. 18: 597-602. PMID 6284678  0.08
1982 Rosenthal T, Holtzman E, Yaron A. Angiotensin-I converting enzyme activity in the sera of captopril-treated hypertensive patients. Clinical and Experimental Hypertension. Part a, Theory and Practice. 4: 367-77. PMID 6280902 DOI: 10.3109/10641968209060749  0.08
1981 Dux S, Rosenfeld J, Yaron A, Carmel A. More on captopril and measurement of angiotensin-converting enzyme. The New England Journal of Medicine. 304: 423-4. PMID 6256629 DOI: 10.1056/NEJM198102123040713  0.08
1979 Yaron A, Carmel A, Katchalski-Katzir E. Intramolecularly quenched fluorogenic substrates for hydrolytic enzymes. Analytical Biochemistry. 95: 228-35. PMID 495959 DOI: 10.1016/0003-2697(79)90210-0  0.08
1979 Carmel A, Ehrlich-Rogozinsky S, Yaron A. A fluorimetric assay for angiotensin-I converting enzyme in human serum. Clinica Chimica Acta; International Journal of Clinical Chemistry. 93: 215-20. PMID 36243 DOI: 10.1016/0009-8981(79)90091-3  0.08
1978 Carmel A, Yaron A. An intramolecularly quenched fluorescent tripeptide as a fluorogenic substrate of angiotensin-I-converting enzyme and of bacterial dipeptidyl carboxypeptidase. European Journal of Biochemistry / Febs. 87: 265-73. PMID 208842  0.08
1978 Campos-Neto A, Schlossman SF, Levine H, Yanovski A, Yaron A. Specificity and genetic restrictions of the guinea-pig immune response to dinitrophenyl-lysyl-alanyl octapeptides. Immunology. 35: 763-9. PMID 102589  0.08
1977 Yaron A, Dunham EK, Stashenko PP, Campos-Neto A, Levine H, Schlossman SF. Immune ascites in the guinea pig: specificity of cells and antibody in an induced peritoneal exudate. Journal of Immunology (Baltimore, Md. : 1950). 119: 968-75. PMID 70481  0.08
1977 Carmel A, Kessler E, Yaron A. Intramolecularly-quenched fluorescent peptides as fluorogenic substrates ofleucine aminopeptidase and inhibitors of clostridial aminopeptidase. European Journal of Biochemistry / Febs. 73: 617-25. PMID 14833  0.08
1976 Kessler E, Yaron A. Extracellular aminopeptidase from Clostridium histolyticum. Methods in Enzymology. 45: 544-52. PMID 13266 DOI: 10.1016/S0076-6879(76)45048-6  0.08
1976 Kessler E, Yaron A. An extracellular aminopeptidase from Clostridium histolyticum. European Journal of Biochemistry / Febs. 63: 271-87. PMID 4318  0.08
1976 Yaron A. [50] Dipeptidyl carboxypeptidase from Escherichia coli Methods in Enzymology. 45: 599-610. DOI: 10.1016/S0076-6879(76)45053-X  0.08
1974 Yaron A, Dunham EK, Schlossman SF. Synthesis and immunological properties of the oligolysyl-N-epsilon-dinitrophenyllysine and oligolysylalanylalanylalanyl-N-epsilon-dinitrophenyllysine peptide series. Biochemistry. 13: 347-54. PMID 4810058  0.08
1974 Jost R, Yaron A. Preparation of soluble and insoluble polysaccharide conjugates of peptides with a free alpha-amino group. Interaction of leucine aminopeptidase with a substrate and an inhibitor bound to agarose and soluble dextran. European Journal of Biochemistry / Febs. 48: 119-29. PMID 4448165  0.08
1973 Carmel A, Zur M, Yaron A, Katchalski E. Use of substrates with fluorescent donor and acceptor chromophores for the kinetic assay of hydrolases. Febs Letters. 30: 11-14. PMID 11947050 DOI: 10.1016/0014-5793(73)80607-6  0.08
1973 Kessler E, Yaron A. A novel aminopeptidase from Clostridium histolyticum. Biochemical and Biophysical Research Communications. 50: 405-12. PMID 4631895 DOI: 10.1016/0006-291X(73)90855-3  0.08
1972 Joshi MS, Yaron A, Lindner HR. Intrauterine gelation of seminal plasma components in the rat after coitus. Journal of Reproduction and Fertility. 30: 27-37. PMID 5035340  0.08
1972 Yaron A, Otey MC, Sober HA, Katchalski E, Ehrlich-Rogozinski S, Berger A. Lysine oligopeptides. Preparation by ion-exchange chromatography. Biopolymers. 11: 607-21. PMID 5016119 DOI: 10.1002/bip.1972.360110306  0.08
1972 Yaron A, Tal N, Berger A. Synthesis and conformation of poly(L-lysyl-L-alanyl-L-alanyl), a sequence-ordered water-soluble copolymer. Biopolymers. 11: 2461-81. PMID 4649728 DOI: 10.1002/bip.1972.360111207  0.08
1972 Yaron A, Mlynar D, Berger A. A dipeptidocarboxypeptidase from E. coli. Biochemical and Biophysical Research Communications. 47: 897-902. PMID 4554640 DOI: 10.1016/0006-291X(72)90577-3  0.08
1971 Yaron A, Katchalski E, Berger A, Fasman GD, Sober HA. The chain length dependence of the conformation for oligomers of L-lysine in aqueous solution: optical rotatory dispersion studies. Biopolymers. 10: 1107-20. PMID 5095086 DOI: 10.1002/bip.360100703  0.08
1970 Joshi MS, Yaron A, Lindner HR. An endopeptidase in the uterine secretion of the proestrous rat and its relation to a sperm decapitating factor. Biochemical and Biophysical Research Communications. 38: 52-7. PMID 5461502 DOI: 10.1016/0006-291X(70)91082-X  0.08
1970 Schlossman SF, Yaron A. Immunochemical studies on the specificity of cellular and antibody-mediated immune reactions. Annals of the New York Academy of Sciences. 169: 108-15. PMID 4244323  0.08
1970 Yaron A, Berger A. [35] Aminopeptidase-P Methods in Enzymology. 19: 521-534. DOI: 10.1016/0076-6879(70)19039-2  0.08
1969 Schlossman SF, Herman J, Yaron A. Antigen recognition: in vitro studies on the specificity of the cellular immune response. The Journal of Experimental Medicine. 130: 1031-45. PMID 5347692  0.08
1968 Yaron A, Mlynar D. Aminopeptidase-P. Biochemical and Biophysical Research Communications. 32: 658-63. PMID 4878817  0.08
1968 Yaron A, Schlossman SF. Preparation and immunologic properties of stereospecific α-dinitrophenylnonalysines Biochemistry. 7: 2673-2681.  0.08
1966 Sober HA, Schlossman SF, Yaron A, Latt SA RUSHIZKY GW. Protein-nucleic acid interaction. I. Nuclease-resistant polylysine-ribonculeic acid complexes. Biochemistry. 5: 3608-16. PMID 4961680  0.08
1965 ARNON R, SELA M, YARON A, SOBER HA. POLYLYSINE-SPECIFIC ANTIBODIES AND THEIR REACTION WITH OLIGOLYSINES. Biochemistry. 4: 948-53. PMID 14337714 DOI: 10.1021/bi00881a023  0.01
1963 YARON A, LUPUN, SELA M, BERGER A. The effect of urea and guanidine on the helix content of poly-N5-(3-hydroxypropyl)-L-glutamine in aqueous-solvent systems. Biochimica Et Biophysica Acta. 69: 430-2. PMID 14002493 DOI: 10.1016/0006-3002(63)91286-1  0.08
1962 SELA M, LUPUN, YARON A, BERGER A. Water-soluble polypeptidyl gliadins. Biochimica Et Biophysica Acta. 62: 594-6. PMID 13910395 DOI: 10.1016/0006-3002(62)90248-2  0.08
2020 Sporny M, Guez-Haddad J, Khazma T, Yaron A, Dessau M, Shkolnisky Y, Mim C, Isupov MN, Zalk R, Hons M, Opatowsky Y. Structural basis for SARM1 inhibition and activation under energetic stress. Elife. 9. PMID 33185189 DOI: 10.7554/eLife.62021  0.04
2019 Sar Shalom H, Goldner R, Golan-Vaishenker Y, Yaron A. Balance between BDNF and Semaphorins gates the innervation of the mammary gland. Elife. 8. PMID 30628891 DOI: 10.7554/eLife.41162  0.04
2017 Goldner R, Yaron A. TIR Axons Apart: Unpredicted NADase Controls Axonal Degeneration. Neuron. 93: 1239-1241. PMID 28334598 DOI: 10.1016/j.neuron.2017.03.005  0.04
2014 Cohen S, Glatstein MM, Scolnik D, Rom L, Yaron A, Otremski S, Ben-Tov A, Reif S. Propofol for pediatric colonoscopy: the experience of a large, tertiary care pediatric hospital. American Journal of Therapeutics. 21: 509-11. PMID 23567786 DOI: 10.1097/MJT.0b013e31826a94e9  0.01
2016 Yaron A, Schuldiner O. Common and Divergent Mechanisms in Developmental Neuronal Remodeling and Dying Back Neurodegeneration. Current Biology : Cb. 26: R628-39. PMID 27404258 DOI: 10.1016/j.cub.2016.05.025  0.01
2014 Cohen S, Gorodnichenco A, Weiss B, Lerner A, Ben-Tov A, Yaron A, Reif S. Polyposis syndromes in children and adolescents: a case series data analysis. European Journal of Gastroenterology & Hepatology. 26: 972-7. PMID 24999926 DOI: 10.1097/MEG.0000000000000143  0.01
2014 Bansal R, Kiku D, Shaliastovich I, Yaron A. Volatility, the Macroeconomy, and Asset Prices Journal of Finance. 69: 2471-2511. DOI: 10.1111/jofi.12110  0.01
2014 Segal G, Shaliastovich I, Yaron A. Good and bad uncertainty: Macroeconomic and financial market implications Journal of Financial Economics. DOI: 10.1016/j.jfineco.2015.05.004  0.01
2014 Maayan K, Simon B, Yan T, Yigal A, Ofer H, Eyal BA, Eran LR, Yaron A, Gad K, Shmuel B, Ariel F. Predictors of improvement in diastolic function after transcatheter aortic valve implantation Journal of Echocardiography. 12: 17-23. DOI: 10.1007/s12574-013-0195-8  0.01
2013 Nelken I, Yaron A, Polterovich A, Hershenhoren I. Stimulus-specific adaptation beyond pure tones. Advances in Experimental Medicine and Biology. 787: 411-8. PMID 23716247 DOI: 10.1007/978-1-4614-1590-9_45  0.24
2012 Yaron A, Hershenhoren I, Nelken I. Sensitivity to complex statistical regularities in rat auditory cortex. Neuron. 76: 603-15. PMID 23141071 DOI: 10.1016/j.neuron.2012.08.025  0.24
2012 Bala M, Yaron A, Koplewitz BZ, Arbell D. Ladd's procedure as an adjunct to treating combined traumatic duodenal and spinal injuries Injury Extra. 43: 28-30. DOI: 10.1016/j.injury.2011.12.029  0.01
2011 Taaseh N, Yaron A, Nelken I. Stimulus-specific adaptation and deviance detection in the rat auditory cortex. Plos One. 6: e23369. PMID 21853120 DOI: 10.1371/journal.pone.0023369  0.24
2011 Huggett M, Ventura G, Yaron A. Sources of lifetime inequality American Economic Review. 101: 2923-2954. DOI: 10.1257/aer.101.7.2923  0.01
2011 Drechsler I, Yaron A. What's vol got to do with it Review of Financial Studies. 24: 1-45. DOI: 10.1093/rfs/hhq085  0.01
2010 Brazowski E, Cohen S, Yaron A, Filip I, Eisenthal A. FOXP3 expression in duodenal mucosa in pediatric patients with celiac disease. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology. 77: 328-34. PMID 21266832 DOI: 10.1159/000322049  0.01
2010 Bansal R, Kiku D, Yaron A. Long run risks, the macroeconomy, and asset prices American Economic Review. 100: 542-546. DOI: 10.1257/aer.100.2.542  0.01
2010 Gençay R, Yaron A, Hackbarth D, Eisfeldt A. Editorial for Challenge Finance Research Letters. 7: 1. DOI: 10.1016/j.frl.2010.02.002  0.01
2009 Levine A, Kori M, Dinari G, Broide E, Shaoul R, Yerushalmi B, On A, Bujanover Y, Pröls M, Greinwald R, Granot E, Weizman Z, Lerner A, Pacht A, Yaron A, et al. Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohn's disease: A randomized placebo-controlled trial Inflammatory Bowel Diseases. 15: 1055-1061. PMID 19229988 DOI: 10.1002/ibd.20881  0.01
2009 Kogan L, Livdan D, Yaron A. Oil futures prices in a production economy with investment constraints Journal of Finance. 64: 1345-1375. DOI: 10.1111/j.1540-6261.2009.01466.x  0.01
2008 Cohen S, Kalinin M, Yaron A, Givony S, Reif S, Santo E. Endoscopic ultrasonography in pediatric patients with gastrointestinal disorders. Journal of Pediatric Gastroenterology and Nutrition. 46: 551-4. PMID 18493211 DOI: 10.1097/MPG.0b013e31815ce571  0.01
2008 Eger R, Reif S, Yaron A, Bojanover Y. [Percutaneous endoscopic gastrostomy (PEG) in children: indications, the procedure, outcomes, short and long-term complications]. Harefuah. 147: 21-4, 95. PMID 18300618  0.01
2008 Ben‐Zvi A, Manor O, Schachner M, Yaron A, Tessier‐Lavigne M, Behar O. [P2.24]: Semaphorin3a promotes neuronal apoptosis in a plexina3‐dependent manner during dorsal root ganglia development International Journal of Developmental Neuroscience. 26: 874-875. DOI: 10.1016/j.ijdevneu.2008.09.149  0.01
2008 Gençay R, Bhattacharyya S, Whited T, Yaron A. Editorial for "Challenge" Finance Research Letters. 5: 1. DOI: 10.1016/j.frl.2007.12.003  0.01
2008 Storesletten K, Telmer C, Yaron A. Asset Prices and Intergenerational Risk Sharing: The Role of Idiosyncratic Earnings Shocks Handbook of the Equity Risk Premium. 565-590. DOI: 10.1016/B978-044450899-7.50028-2  0.01
2007 Yaron A, Bar-Zohar M, Horesh N. Miniature stereoscopic video system provides real-time 3D registration and image fusion for minimally invasive surgery Proceedings of Spie - the International Society For Optical Engineering. 6490. DOI: 10.1117/12.714147  0.01
2007 Yaron A, Uri BZ, Ahron R. On the Duty of Care of Institutional Investors: Evidence on Participation of Mutual Fund Managers in Shareholder Meetings in Israel Advances in Financial Economics. 12: 75-90. DOI: 10.1016/S1569-3732(07)12004-1  0.01
2007 Storesletten K, Telmer CI, Yaron A. Asset pricing with idiosyncratic risk and overlapping generations Review of Economic Dynamics. 10: 519-548. DOI: 10.1016/j.red.2007.02.004  0.01
2006 Yaron A, Shechterman M, Horesh N. Blur spot limitations in distal endoscope sensors Proceedings of Spie - the International Society For Optical Engineering. 6055. DOI: 10.1117/12.659385  0.01
2006 Gomes JF, Yaron A, Zhang L. Asset pricing implications of firms' financing constraints Review of Financial Studies. 19: 1321-1356. DOI: 10.1093/rfs/hhj040  0.01
2006 Huggett M, Ventura G, Yaron A. Human capital and earnings distribution dynamics Journal of Monetary Economics. 53: 265-290. DOI: 10.1016/j.jmoneco.2005.10.013  0.01
2005 Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R, Agostoni C, Ball P, Carnielli V, Chaloner C, Clayton J, Colomb V, Dijsselhof M, Fusch C, Gandullia P, Genzel-Boroviczeny O, ... ... Yaron A, et al. Report on the guidelines on parenteral nutrition in infants, children and adolescents Clinical Nutrition. 24: 1105-1109. PMID 16429487 DOI: 10.1016/j.clnu.2005.09.004  0.01
2005 Zung A, Yaron A, Altman Y, Zadik Z. Beta-adrenergic hyperresponsiveness in compensated hypothyroidism associated with Down syndrome. Pediatric Research. 58: 66-70. PMID 15774852 DOI: 10.1203/01.PDR.0000156227.64424.20  0.01
2005 Jallath-Coria E, Mukhopadhyay T, Yaron A. How well do Mexican banks manage their reserves? Journal of Money, Credit and Banking. 37: 623-643. DOI: 10.1353/mcb.2005.0044  0.01
2005 Dufossé L, Galaup P, Yaron A, Arad SM, Blanc P, Murthy KNC, Ravishankar GA. Microorganisms and microalgae as sources of pigments for food use: A scientific oddity or an industrial reality? Trends in Food Science and Technology. 16: 389-406. DOI: 10.1016/j.tifs.2005.02.006  0.01
2005 Bansal R, Khatchatrian V, Yaron A. Interpretable asset markets? European Economic Review. 49: 531-560. DOI: 10.1016/j.euroecorev.2004.09.002  0.01
2004 Bansal R, Yaron A. Risks for the long run: A potential resolution of asset pricing puzzles Journal of Finance. 59: 1481-1509. DOI: 10.1111/j.1540-6261.2004.00670.x  0.01
2003 Gomes JF, Yaron A, Zhang L. Asset prices and business cycles with costly external finance Review of Economic Dynamics. 6: 767-788. DOI: 10.1016/S1094-2025(03)00061-9  0.01
1996 Hansen LP, Heaton J, Yaron A. Finite-sample properties of some alternative GMM estimators Journal of Business and Economic Statistics. 14: 262-280.  0.01
1995 Yaron A, Dvir I, Maislos M, Mokady S, (Malis) Arad S. The red microalga Rhodella reticulata as a source of a dietary ω-3 highly unsaturated fatty acid- Eicosapentaenoic acid Developments in Food Science. 37: 665-674. DOI: 10.1016/S0167-4501(06)80188-3  0.01
1993 LeRoith D, Adamo ML, Shemer J, Lanau F, Shen-Orr Z, Yaron A, Roberts CT, Clemmons DR, Sheikh MS, Shao ZM. Retinoic acid inhibits growth of breast cancer cell lines: the role of insulin-like growth factor binding proteins. Growth Regulation. 3: 78-80. PMID 7683539  0.01
1993 Shemer J, Yaron A, Werner H, Shao ZM, Sheikh MS, Fontana JA, LeRoith D, Roberts CT. Regulation of insulin-like growth factor (IGF) binding protein-5 in the T47D human breast carcinoma cell line by IGF-I and retinoic acid. The Journal of Clinical Endocrinology and Metabolism. 77: 1246-50. PMID 7521344 DOI: 10.1210/jcem.77.5.7521344  0.01
1993 Yaron A. Characterization of Aloe vera gel before and after autodegradation, and stabilization of the natural fresh gel Phytotherapy Research. 7: S11-S13.  0.01
1992 Arad S(, Yaron A. Natural pigments from red microalgae for use in foods and cosmetics Trends in Food Science and Technology. 3: 92-97. DOI: 10.1016/0924-2244(92)90145-M  0.01
1992 Yaron A. Stabilization of aloe vera gel by interaction with sulfated polysaeeharides from red microalgae and with xanthan gum Journal of Agricultural and Food Chemistry®. 40: 1316-1320.  0.01
1987 Fleminger G, Yaron A. Application of immobilized aminopeptidases to the sequential hydrolysis of proline-containing peptides. Methods in Enzymology. 136: 170-8. PMID 3683192  0.01
1982 Yaron A, Samoiloff V, Benzioni A. Absorption and distribution of orally administered jojoba wax in mice. Lipids. 17: 169-71. PMID 7087693 DOI: 10.1007/BF02535098  0.01
1982 Yaron A, Benzioni A, More I. Physiological toleration of jojoba wax in laboratory animals Journal of the Society of Cosmetic Chemists of Japan. 33: 141-148.  0.01
1980 Yaron A, Benzioni A, More I. Absorption and distribution of jojoba wax injected subcutaneously into mice Lipids. 15: 889-894. DOI: 10.1007/BF02534410  0.01
1976 Bernstein A, Yaron A, Globerson A. Minimal requirements for in vitro activity of chemically defined synthetic antigens as immunogenic carrier molecules. Cellular Immunology. 27: 298-308. PMID 1009584 DOI: 10.1016/0008-8749(76)90236-7  0.01
1976 Yaron A. Dipeptidyl carboxypeptidase from Escherichia coli. Methods in Enzymology. 45: 599-610. PMID 13271  0.01
1972 Letan A, Yaron A. Some practical aspects connected with the presence of calcium in soybean oils Journal of the American Oil Chemists Society. 49: 702. DOI: 10.1007/BF02609204  0.01
1972 Tene Z, Yaron A, Letan A. Modification of a procedure for analytical hydrogenation of edible oils Journal of the American Oil Chemists' Society. 49: 52-56. DOI: 10.1007/BF02545140  0.01
1968 Schlossman SF, Levine H, Yaron A. Studies on the specificity of antibody to 2,4-Dini-trophenyl-poly-L-lysines. Biochemistry. 7: 1-7. PMID 5758544  0.01
1968 Yaron A, Schlossman SF. Preparation and immunologic properties of stereospecific alpha-dinitrophenylnonalysines. Biochemistry. 7: 2673-81. PMID 5660082  0.01
1968 Cogan U, Yaron A, Berk Z, Zimmermann G. Effect of processing conditions on the nutritive value of isolated soybean proteins Journal of Agricultural and Food Chemistry. 16: 196-198.  0.01
1967 Cogan U, Yaron A, Berk Z, Mizrahi S. Isolation of soybean protein: Effect of processing conditions on yields and purity Journal of the American Oil Chemists Society. 44: 321-324. DOI: 10.1007/BF02635625  0.01
1966 Schlossman SF, Ben-Efraim S, Yaron A, Sober HA. Immunochemical studies on the antigenic determinants required to elicit delayed and immediate hypersensitivity reactions. The Journal of Experimental Medicine. 123: 1083-95. PMID 5941782  0.01
1965 Yaron A, Berger A. Multi-chain polyamino acids containing glutamic acid, aspartic acid and proline. Biochimica Et Biophysica Acta. 107: 307-32. PMID 5880557  0.01
1965 Schlossman SF, Yaron A, Ben-Efraim S, Sober HA. Immunogenicity of a series of alpha,N-DNP-L-lysines. Biochemistry. 4: 1638-45. PMID 5865661  0.01
1965 Yaron A, Sober HA. Ion-exchange electrophoresis of oligonucleotides and oligopeptides. Analytical Biochemistry. 12: 173-88. PMID 5850399  0.01
1963 YARON A, BERGER A. The determination of the molecular weight of poly-L-lysine. Biochimica Et Biophysica Acta. 69: 397-9. PMID 14002492  0.01
1961 LOEBL WY, ULLMAN TD, YARON A, SELA M, BERGER A, KATCHALSKI E. Evaluation of multichain polyglutamic acid as a possible plasma expander. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 108: 661-3. PMID 14466196 DOI: 10.3181/00379727-108-27027  0.01
Hide low-probability matches.